Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-29 / J. Immunol. 2015 Jul;195(1):367-76https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-29 / J. Immunol. 2015 Jul;195(1):367-762015-05-29 00:00:002019-02-15 08:47:19Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-28 / Immunotherapy 2015;7(8):855-60https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-28 / Immunotherapy 2015;7(8):855-602015-05-28 00:00:002021-11-16 07:55:05Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-27 / Cancer Treat. Rev. 2015 Nov;41(9):742-53https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-27 / Cancer Treat. Rev. 2015 Nov;41(9):742-532015-05-27 00:00:002019-02-15 09:18:02Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-27 / Onco Targets Ther 2015;8:1265-70https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-27 / Onco Targets Ther 2015;8:1265-702015-05-27 00:00:002015-05-27 00:00:00Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-21 / World J. Gastroenterol. 2015 May;21(19):5778-93https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-21 / World J. Gastroenterol. 2015 May;21(19):5778-932015-05-21 00:00:002015-05-21 00:00:00Gastric cancer and the epoch of immunotherapy approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-19 / Radiother Oncol 2015 Nov;117(2):217-22https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-19 / Radiother Oncol 2015 Nov;117(2):217-222015-05-19 00:00:002015-05-19 00:00:00Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-18 / BJU Int. 2015 Sep;116(3):321-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-18 / BJU Int. 2015 Sep;116(3):321-92015-05-18 00:00:002019-02-15 08:45:12Advances in the understanding of cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-15 / Int J Hyperthermia 2015;31(6):609-14https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-15 / Int J Hyperthermia 2015;31(6):609-142015-05-15 00:00:002019-02-15 09:18:00Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-05-07 / Cell Death Dis 2015 May;6:e1758https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-05-07 / Cell Death Dis 2015 May;6:e17582015-05-07 00:00:002019-02-15 09:22:47IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-04-23 / Swiss Med Wkly 2015;145:w14133https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-04-23 / Swiss Med Wkly 2015;145:w141332015-04-23 00:00:002015-04-23 00:00:00Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-04-18 / Breast 2015 Aug;24(4):418-25https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-04-18 / Breast 2015 Aug;24(4):418-252015-04-18 00:00:002015-04-18 00:00:00Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002015-04-14 / Chonnam Med J 2015 Apr;51(1):1-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2015-04-14 / Chonnam Med J 2015 Apr;51(1):1-72015-04-14 00:00:002019-02-15 08:51:23Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
Phase II randomized trial of autologous tumor lysate dendritic cell vaccine (ADC) plus best supportive care (BSC) compared with BSC, in pre-treated advanced colorectal cancer patients.
Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.
Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future
Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901
Gastric cancer and the epoch of immunotherapy approaches
Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients
Advances in the understanding of cancer immunotherapy
Vaccine immunotherapy in lung cancer: Clinical experience and future directions
Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity
Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway
Hyperthermia and reirradiation for locoregional recurrences in preirradiated breast cancers: a single institutional experience
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer
Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma
Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic